A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Establishment of Deep Hypothermic Circulatory Arrest in Rats

2.5K views

⸱

DOI:

10.3791/63571

⸱

December 16th, 2022

 , 

In This Article

Summary

This protocol presents the establishment of deep hypothermic circulatory arrest in rats, which can be applied to investigate systemic inflammatory response syndrome, ischemia/reperfusion injury, oxidative stress, neuroinflammation, etc.

Abstract

Deep hypothermic circulatory arrest (DHCA) is routinely applied during surgeries for complex congenital heart disease and aortic arch disease. The present study aims to provide a method for establishing DHCA in rats. To evaluate the impact of the DHCA process on vital signs, a normal temperature cardiopulmonary bypass (CPB) rat model without circulatory arrest was used as a control. As expected, DHCA led to a significant decrease in body temperature and mean arterial blood pressure. The blood gas analysis indicated that DHCA increased lactic acid levels but did not influence the blood pH and the concentrations of hemoglobin, hematocrit, Na+, Cl−, K+, and glucose. Furthermore, compared with the normal temperature CPB rats, the results of the transmission electron microscopy showed a mild increase in hippocampal autophagosomes in the DHCA rats.

Introduction

Deep hypothermic circulatory arrest (DHCA) has been used in cardiac surgery since 19531. DHCA involves reducing the patient's core temperature to profoundly hypothermic levels (15-22 °C) before globally interrupting the blood flow to the body2. The circulatory arrest can provide a relatively bloodless operating field. Deep hypothermia decreases the metabolism, especially in the brain and myocardium, which is an effective method of protection against ischemia3. DHCA is commonly applied during surgeries for complex congenital heart disease, aortic arch disease, and even renal or ....

Access restricted. Please log in or start a trial to view this content.

Protocol

The protocols underwent an institutional review and received approval from the Institutional Animal Care and Use Committee, Fuwai Hospital, Chinese Academy of Medical Sciences (FW-2021-0005). All the experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.

NOTE: Male Sprague-Dawley rats (weight: 500-600 g, age: 12-14 weeks) were kept under standard laboratory conditions with free access to food and water. The rats were randomly allocated into two groups (n = 6, each group): the DHCA group, and the normal temperature CPB group (NtCPB group).....

Access restricted. Please log in or start a trial to view this content.

Results

As the control group, the normal temperature CPB (NtCPB) rats without circulatory arrest showed a stable mean arterial blood pressure (MAP) and body temperature during the whole procedure, while the MAP of the DHCA rats decreased during the cardiac arrest (p < 0.01, Figure 3A). The temperature of the DHCA rats dropped quickly during the cooling phase and recovered gradually during the rewarming phase. When weaning the rats off the DHCA circuits, the temperature of the DHCA rats r.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Cannulation is the most fundamental procedure for establishing DHCA in rats. Before cannulation, soaking the artery with 0.5 mL of 2% lidocaine will make it easier to cannulate. After cannulation, heparinization with 500 IU/kg heparin via the external jugular vein is necessary to avoid microthrombus formation17. We have repeatedly found that this dose of heparin can achieve the goal of an activated clotting time (ACT) >480 s. The rewarming period is the most difficult part. It took mor.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors thank Liang Zhang for helping to collect the video data during the experiment. This study was supported by the National Natural Science Foundation of China (Grant number: 82070479) and the Fundamental Research Funds for the Central Universities (Grant number: 3332022128).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Heat ExchangerXi’an Xijing Medical Appliance Co., LtdAnimal-M
Membrane OxygenatorDongguan Kewei Medical Instrument Co., Ltd.Micro-M
MonitorChengdu Techman Co., LtdBL-420s
Roller PumpChangzhou Prefluid Technology Co.,LtdBL100
SD RatHFK Bioscience Co.,Ltd./
SevofluraneMaruishi Pharmaceutical Co. LtdH20150020
ShaverHangzhou Huayuan Pet Products Co.,Ltd./
VaporizerSPACECABS/
VentilatorShanghai Alcott Biotech Co., LtdALC-V8S
Water TankMaquet Critical Care ABJostra HCU20-600

References

  1. Lewis, F. J., Taufic, M. Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case. Surgery. 33 (1), 52-59 (1953).
  2. Miler, R. D., et al. Miller's Anesthesia., eighth edition....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Cardiopulmonary BypassRat ModelBlood Gas AnalysisMean Arterial PressureHippocampal AutophagosomesTransmission Electron MicroscopyNeuroinflammationSystemic Inflammatory ResponseBody Temperature